Lemborexant
DAYVIGO
Orexin Receptor Antagonist
NADAC/unit
$11.5704
No Shortage
Tier 1: 9.7%
PA Req: 11.6%
vs. brand DAYVIGO: Generic saves up to -16% per unit
Generic Manufacturers
EISAI INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.
